These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Viable lymphocytes in fresh frozen plasma as a potential source of graft-versus-host disease: risks and solutions. Brando B Blood Transfus; 2021 Nov; 19(6):445-447. PubMed ID: 34369867 [No Abstract] [Full Text] [Related]
5. Flow-based analysis of cell division identifies highly active populations within plasma products during mixed lymphocyte cultures. Lazarski CA; Toner K; Keller MD; Luban N; Young PP; Bollard CM; Wagner SJ; Hanley PJ Blood Transfus; 2021 Nov; 19(6):456-466. PubMed ID: 34369863 [TBL] [Abstract][Full Text] [Related]
6. Transfusion-associated graft versus host disease in the immunocompetent patient: an ongoing problem. Jawa RS; Young DH; Stothert JC; Kulaylat MN; Landmark JD J Intensive Care Med; 2015 Mar; 30(3):123-30. PubMed ID: 23792801 [TBL] [Abstract][Full Text] [Related]
7. Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder. Ní Loingsigh S; Flegel WA; Hendrickson JE; Tormey CA Br J Haematol; 2020 Dec; 191(5):653-657. PubMed ID: 32738068 [No Abstract] [Full Text] [Related]
8. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force. Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157 [No Abstract] [Full Text] [Related]
9. Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease. Pritchard AE; Shaz BH Arch Pathol Lab Med; 2016 Oct; 140(10):1092-7. PubMed ID: 27684981 [TBL] [Abstract][Full Text] [Related]
10. Is pathogen reduction an acceptable alternative to irradiation for risk mitigation of transfusion-associated graft versus host disease? Li M; Irsch J; Corash L; Benjamin RJ Transfus Apher Sci; 2022 Apr; 61(2):103404. PubMed ID: 35288055 [TBL] [Abstract][Full Text] [Related]
11. Prevention of post-transfusion graft-versus-host disease. Tasaki T; Ohto H; Abe R Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133 [TBL] [Abstract][Full Text] [Related]
12. Developments in the prevention of transfusion-associated graft-versus-host disease. Fast LD Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439 [TBL] [Abstract][Full Text] [Related]
13. Guidelines on the use of irradiated blood components. Foukaneli T; Kerr P; Bolton-Maggs PHB; Cardigan R; Coles A; Gennery A; Jane D; Kumararatne D; Manson A; New HV; Torpey N; Br J Haematol; 2020 Dec; 191(5):704-724. PubMed ID: 32808674 [No Abstract] [Full Text] [Related]